Deleted Tweets From Scott Gottlieb, R-D.C.

Today, #FDA and @CDCgov announced that the outbreak of Cyclospora illnesses linked to Fresh Express salad mix served at McDonald’s has ended. In all, 511 consumers were infected with the illness in 15 states and NYC. Tragically, some became very ill. https://t.co/A4a1uBFjAb

RT @SquawkCNBC: TUNE IN ALERT: Dr. Scott Gottlieb @SGottliebFDA FDA Commissioner @ 7:10a ET today! https://t.co/7mvfTWHBtV

RT @FDA_ORA: Are dietary supplements FDA approved? Learn the answer to this and other frequently asked questions about drugs he… https://t.co/8gfcEsT1Ne

As part of our efforts to expedite patient access to certain lower-risk devices, we’re taking new steps to better leverage reviews provided by experts in #FDA-recognized third party review orgs. New #FDA plan issued today and guidance open for comment. https://t.co/3fPcuFnH8M

To encourage innovation and timely access for patients, #FDA issued a plan and draft guidance to improve third-party review of certain lower-risk medical devices. Now open for public comment. FDA welcomes suggestions on eligible and ineligible devices. https://t.co/3fPcuFnH8M

Learn steps you can take to protect your food and water during hurricanes and other storms https://t.co/HUlGf2cnP1 #HurricaneFlorence https://t.co/ZgrrQZuOGu

RT @SecAzar: #HurricaneFlorence is an intense storm and is predicted to be highly destructive—posing a significant threat to the… https://t.co/RrSIt36m4j

Promoting Generic Drug Competition: >60% of all metered dose inhalers and dry powder inhaler products have product-specific guidances (PSGs) and >55% of all nasal products have PSGs. Follow recommendations in the PSGs! #CDERSBIA View PSGs here: https://t.co/ploEbfzW8w. https://t.co/4MYOLyBSu6

RT @ZacharyBrennan: lots of change is afoot in the diagnostics/LDT/in vitro clinical test space - will be curious to see what Congress… https://t.co/VgCysJYsjK

RT @HHSGov: #ICYMI: @US_FDA issued more than 1,300 warning letters and civil money penalty complaints to retailers who illegall… https://t.co/ljNjS1Cmfq

RT @FDAOMH: Do you use insulin? Learn more about insulin storage during an emergency that may include a power outage:… https://t.co/PeQfGgSCfM

RT @FDA_Track: FDA provides update on its ongoing investigation into #valsartan products; and reports on the finding of an additio… https://t.co/YpYAd6RwIz

RT @ElizabethJungma: Check out @pewhealth’s latest update on the number of antibiotics and nontraditional products in clinical developme… https://t.co/MH2ERovXv7

RT @FDAOncology: Ever wonder what goes on at FDA drug label meetings? This talented pharmacy student who interned here this summer gets it… QT @garucaselogs: Creating a drug label (AKA package inserts) requires a lot of efforts from the FDA team, but sadly many pharmacists… https://t.co/DUaK5UCMX5)

This plan also supports the judicious use of antimicrobials in food-producing animals and is driven by the concept that medically important antimicrobial drugs should only be used in animals when necessary for the treatment, control or prevention of specific diseases.

This plan builds on important steps #FDA has taken to eliminate production uses of medically important antimicrobials and bring all remaining therapeutic uses under veterinary oversight.

RT @FDA_Drug_Info: FDA announces the Request for Information (RFI), “Development of New Antibacterial Drugs Active Against Multi-Drug… https://t.co/KriPDkMlun

THREAD: Today, #FDA unveiled its five-year action plan for supporting antimicrobial stewardship in veterinary settings https://t.co/S57feDUnHe

#FDA released a Request for Information to identify research areas where regulatory science can lead to new tools and standards that support the development of antibacterial treatments. https://t.co/Y4BMpMLIjy

RT @US_FDA: Thank you for joining us and @SGottliebFDA at @pewtrusts for our announcement of FDA's Strategic Approach for Comba… https://t.co/tkvkSKytLQ

Today, #FDA and @CDCgov announced that the outbreak of Cyclospora illnesses linked to Fresh Express salad mix served at McDonald’s has ended. In all, 511 consumers were infected with the illness in 15 states and NYC. Tragically, some became very ill. https://t.co/A4a1uBFjAb

RT @SquawkCNBC: TUNE IN ALERT: Dr. Scott Gottlieb @SGottliebFDA FDA Commissioner @ 7:10a ET today! https://t.co/7mvfTWHBtV

RT @FDA_ORA: Are dietary supplements FDA approved? Learn the answer to this and other frequently asked questions about drugs he… https://t.co/8gfcEsT1Ne

As part of our efforts to expedite patient access to certain lower-risk devices, we’re taking new steps to better leverage reviews provided by experts in #FDA-recognized third party review orgs. New #FDA plan issued today and guidance open for comment. https://t.co/3fPcuFnH8M

To encourage innovation and timely access for patients, #FDA issued a plan and draft guidance to improve third-party review of certain lower-risk medical devices. Now open for public comment. FDA welcomes suggestions on eligible and ineligible devices. https://t.co/3fPcuFnH8M

Learn steps you can take to protect your food and water during hurricanes and other storms https://t.co/HUlGf2cnP1 #HurricaneFlorence https://t.co/ZgrrQZuOGu

RT @SecAzar: #HurricaneFlorence is an intense storm and is predicted to be highly destructive—posing a significant threat to the… https://t.co/RrSIt36m4j

Promoting Generic Drug Competition: >60% of all metered dose inhalers and dry powder inhaler products have product-specific guidances (PSGs) and >55% of all nasal products have PSGs. Follow recommendations in the PSGs! #CDERSBIA View PSGs here: https://t.co/ploEbfzW8w. https://t.co/4MYOLyBSu6

RT @ZacharyBrennan: lots of change is afoot in the diagnostics/LDT/in vitro clinical test space - will be curious to see what Congress… https://t.co/VgCysJYsjK

RT @HHSGov: #ICYMI: @US_FDA issued more than 1,300 warning letters and civil money penalty complaints to retailers who illegall… https://t.co/ljNjS1Cmfq

RT @FDAOMH: Do you use insulin? Learn more about insulin storage during an emergency that may include a power outage:… https://t.co/PeQfGgSCfM

RT @FDA_Track: FDA provides update on its ongoing investigation into #valsartan products; and reports on the finding of an additio… https://t.co/YpYAd6RwIz

RT @ElizabethJungma: Check out @pewhealth’s latest update on the number of antibiotics and nontraditional products in clinical developme… https://t.co/MH2ERovXv7

RT @FDAOncology: Ever wonder what goes on at FDA drug label meetings? This talented pharmacy student who interned here this summer gets it… QT @garucaselogs: Creating a drug label (AKA package inserts) requires a lot of efforts from the FDA team, but sadly many pharmacists… https://t.co/DUaK5UCMX5)

This plan also supports the judicious use of antimicrobials in food-producing animals and is driven by the concept that medically important antimicrobial drugs should only be used in animals when necessary for the treatment, control or prevention of specific diseases.

This plan builds on important steps #FDA has taken to eliminate production uses of medically important antimicrobials and bring all remaining therapeutic uses under veterinary oversight.

RT @FDA_Drug_Info: FDA announces the Request for Information (RFI), “Development of New Antibacterial Drugs Active Against Multi-Drug… https://t.co/KriPDkMlun

THREAD: Today, #FDA unveiled its five-year action plan for supporting antimicrobial stewardship in veterinary settings https://t.co/S57feDUnHe

#FDA released a Request for Information to identify research areas where regulatory science can lead to new tools and standards that support the development of antibacterial treatments. https://t.co/Y4BMpMLIjy

RT @US_FDA: Thank you for joining us and @SGottliebFDA at @pewtrusts for our announcement of FDA's Strategic Approach for Comba… https://t.co/tkvkSKytLQ